I hate this stock... Al needs to be more focused on firing SNY and bringing in a US BP partner that will start marketing this drug properly.
Won't ever be ever to hold gains until SNY gets off their lazy #$%$ and does their part of the deal. If I were Al, I'd back out of the deal and go find someone here in the US that actually gives a #$%$.
Can't believe that people still think that there is still going to be a buyout scenario. They are locked in with SNY and will be stuck with the lousy 35% share of revenue. The only thing to get excited about are the milestones at this point, and if script numbers don't pick up, then you can forget about those as well. SNY isn't doing there job bottom line.
yep, look at all the money you're going to lose you moron. $4.00 by friday watch and learn.
It's tremendously undervalued here. FDA approved and a 2 billion tax write off. I don't understand why you would try to short here, but nothing makes sense with this company.
I told you yesterday that we'd be down .50 cents after this call because of the pathetic job that management has been doing through 2015. Al has lost his mind and a billion dollars. I feel bad for MNKD's board, shareholders, and patients. Market won't give them enough time to show the public how good this drug can be, plus Big Pharma doesnt like competition like this coming into the game that can change everything. They will do anything to keep them silenced.
If you think this hurts, then wait till tomorrow if management doesnt have anything earth shattering to say. They have to come with big news tomorrow or this thing drops another .50 cents easily.
You were correct about the 10% sell off after the pop yesterday. Have to applaud you for that
If Afreeza totally collapses because SNY didn't fulfill any of it's duties to market the drug, then I hope that the BOD at MNKD will be able to see this and prove in a court of law that they purposefully did this. If they won, we'd be looking at a massive settlement, but management for MNKD is too daft so this is wishful thinking.
I can't believe that it's at this price. These levels are lower than phase III trials / results, adcom, fda approval, partnership... How can a drug that went from concept to an actual solution be this cheap?? This is all because of the SNY partnership that has become a disaster. I wish we had a different partner looking back because SNY has basically sabotaged Afreeza up to this point. They won't buy them, they won't do anything it seems. They just want to sit back and watch this drug disappear. I hate to be pessimistic but I can't believe that investors and patients are suffering through this train wreck of a launch.
This has been my only fear since investing in MNKD. I often worry that they paid the $250 million just to keep the drug from being discovered and to insure that their main line of treatments isn't threatened. So far after looking at what they've done since launch, it's definitely not out of the question.
I'm long but I have to agree with you that we will see a crash this week, so starting a short position is a better call here. I'm not in it for a quick trade however, so the price now is of no matter to me.
Pop and drop for no reason. This is pretty typical price action. They are going to keep bringing it down watch.
Not sure how they can continue shorting under $5 now since this is considered a non marginable security, but it still happens all the time to OTC stocks and pink sheet companies. I don't see them stopping until they bury the stock, but if any decent news comes out then they are toast.
The company is worth 2 billion in tax write offs alone, but you wouldn't know that because you haven't done any research.
It's called capitulation! It never makes sense. The trend is still down, just be patient we are in significantly oversold territory.